Your browser doesn't support javascript.
loading
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model.
Péricat, David; Leon-Icaza, Stephen Adonai; Sanchez Rico, Marina; Mühle, Christiane; Zoicas, Iulia; Schumacher, Fabian; Planès, Rémi; Mazars, Raoul; Gros, Germain; Carpinteiro, Alexander; Becker, Katrin Anne; Izopet, Jacques; Strub-Wourgaft, Nathalie; Sjö, Peter; Neyrolles, Olivier; Kleuser, Burkhard; Limosin, Frédéric; Gulbins, Erich; Kornhuber, Johannes; Meunier, Etienne; Hoertel, Nicolas; Cougoule, Céline.
Afiliação
  • Péricat D; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Leon-Icaza SA; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Sanchez Rico M; Faculté de Santé, Université Paris Cité, 75006 Paris, France.
  • Mühle C; Département de Psychiatrie et d'Addictologie de l'Adulte et du Sujet Agé, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Psychiatrie et Addictologie, Hôpital Corentin-Celton, 92130 Issy-les-Moulineaux, France.
  • Zoicas I; INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, 75014 Paris, France.
  • Schumacher F; Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University of Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Planès R; Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University of Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Mazars R; Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2-4, 14195 Berlin, Germany.
  • Gros G; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Carpinteiro A; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Becker KA; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Izopet J; Institute for Molecular Biology, University Medicine Essen, University of Duisburg-Essen, 47057 Essen, Germany.
  • Strub-Wourgaft N; Institute for Molecular Biology, University Medicine Essen, University of Duisburg-Essen, 47057 Essen, Germany.
  • Sjö P; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), Université Toulouse, CNRS, INSERM, UPS, 31300 Toulouse, France.
  • Neyrolles O; Laboratoire de Virologie, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France.
  • Kleuser B; Drugs for Neglected Diseases Initiative, 1202 Geneva, Switzerland.
  • Limosin F; Drugs for Neglected Diseases Initiative, 1202 Geneva, Switzerland.
  • Gulbins E; Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, 31000 Toulouse, France.
  • Kornhuber J; Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2-4, 14195 Berlin, Germany.
  • Meunier E; Faculté de Santé, Université Paris Cité, 75006 Paris, France.
  • Hoertel N; Département de Psychiatrie et d'Addictologie de l'Adulte et du Sujet Agé, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Psychiatrie et Addictologie, Hôpital Corentin-Celton, 92130 Issy-les-Moulineaux, France.
  • Cougoule C; INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, 75014 Paris, France.
Int J Mol Sci ; 23(21)2022 Nov 07.
Article em En | MEDLINE | ID: mdl-36362409
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article